title: Comparing the efficacy of FeLV vaccines: comment on: Stuke, K. et al. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge. Vaccine 2014;32(22):2599-603.
authors.affiliation: Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland. Electronic address: rhofmann@vetclinics.uzh.ch.
authors.forename: Regina
authors.initials: R
authors.lastname: Hofmann-Lehmann
authors.affiliation: Tulane University, 1440 Canal Street, Suite 2400 (TW-5), New Orleans, LA 70112-2709, United States. Electronic address: llevy@tulane.edu.
authors.forename: Laura S
authors.initials: LS
authors.lastname: Levy
authors.affiliation: MRC-University of Glasgow, Centre for Virus Research, Garscube Campus, 464 Bearsden Road, Glasgow G61 1QH, Scotland, UK. Electronic address: brian.willett@glasgow.ac.uk.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Willett
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000097:blood*; D015683:Gene Products, gag / Q000097:blood*; D016582:Leukemia, Feline / Q000517:prevention & control*; D015682:Retroviridae Proteins, Oncogenic / Q000008:administration & dosage*; D014611:Vaccination / Q000662:veterinary*; D014765:Viral Vaccines / Q000008:administration & dosage*
chemical_list: D000956:Antigens, Viral; D015683:Gene Products, gag; D015682:Retroviridae Proteins, Oncogenic; D014765:Viral Vaccines